Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Epirubicin

Known as: epi-ADR, Epirubicina, 4' Epi Adriamycin 
A 4'-epi-isomer of the anthracycline antineoplastic antibiotic doxorubicin. Epirubicin intercalates into DNA and inhibits topoisomerase II, thereby… Expand
National Institutes of Health

Related topics

Related topics

48 relations
100 ML Epirubicin Hydrochloride 2 MG/ML Injection100 ML Epirubicin Hydrochloride 2 MG/ML Injection [Ellence]Drug AllergyIn Blood
Expand

Narrower (30)

3'-deamino-3'-hydroxydoxorubicinCEFT protocolCEO-PE protocolCEOP-B protocol
Expand

Broader (1)

Antibiotics, Antineoplastic

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2020
Highly Cited
2020
How to fight an infodemic
Highly Cited
2011
Highly Cited
2011
RIBBON-1: randomized, double-blind, placebo-controlled, phase III trial of chemotherapy with or without bevacizumab for first-line treatment of human epidermal growth factor receptor 2-negative…
PURPOSE This phase III study compared the efficacy and safety of bevacizumab (BV) when combined with several standard… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • table 2
Highly Cited
2010
Highly Cited
2010
Laminar analysis of 7T BOLD using an imposed spatial activation pattern in human V1
With sufficient image encoding, high-resolution fMRI studies are limited by the biological point-spread of the hemodynamic signal… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Highly Cited
2004
Highly Cited
2004
A randomized clinical trial of combination chemotherapy with and without low‐molecular‐weight heparin in small cell lung cancer
Summary.  Background Small cell lung cancer (SCLC) is a chemotherapy‐responsive tumor type but most patients ultimately… Expand
Highly Cited
2001
Highly Cited
2001
Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.
BACKGROUND The HER2 gene, which encodes the growth factor receptor HER2, is amplified and HER2 is overexpressed in 25 to 30… Expand
  • figure 1
  • table 3
  • table 4
Highly Cited
2001
Highly Cited
2001
Adjuvant chemotherapy for adult soft tissue sarcomas of the extremities and girdles: results of the Italian randomized cooperative trial.
PURPOSE Adjuvant chemotherapy for soft tissue sarcoma is controversial because previous trials reported conflicting results. The… Expand
Highly Cited
2001
Highly Cited
2001
USE OF CHEMOTHERAPY PLUS A MONOCLONAL ANTIBODY AGAINST HER 2 FOR METASTATIC BREAST CANCER THAT OVEREXPRESSES HER 2
A BSTRACT Background The HER2 gene, which encodes the growth factor receptor HER2, is amplified and HER2 is overexpressed in 25… Expand
  • figure 1
  • table 3
  • table 4
Review
1998
Review
1998
Prognostic factors in patients with pleural mesothelioma: the European Organization for Research and Treatment of Cancer experience.
PURPOSE Identification of prognostic factors in patients with malignant pleural mesothelioma based on prospectively collected… Expand
Review
1996
Review
1996
Epithelial M Cells: Gateways for Mucosal Infection and Immunization
M cell transport is an important factor in induction of mucosal immune responses and is exploited by pathogenic microorganisms… Expand
  • figure 1
  • figure 2
Highly Cited
1995
Highly Cited
1995
Randomised comparison of fluorouracil, epidoxorubicin and methotrexate (FEMTX) plus supportive care with supportive care alone in patients with non-resectable gastric cancer.
A phase III randomised study, comparing treatment with fluorouracil, epidoxorubicin and methotrexate (FEMTX) with the best… Expand
  • table I
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE